Boston Scientific CorporationBSXNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+39.9%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+39.9%/yr
vs -4.0%/yr prior
Acceleration
+43.9pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 27.06% |
| 2024 | 14.21% |
| 2023 | 6.88% |
| 2022 | 9.88% |
| 2021 | 5.34% |
| 2020 | -2.64% |
| 2019 | 5.48% |
| 2018 | 11.63% |
| 2017 | 8.37% |
| 2016 | 5.02% |